Gene: lnc-IRX3-80
Basic information
LNCipedia gene ID: lnc-IRX3-80
Location (hg38): chr16:54845189-54930942
Strand: -
Class: antisense
Sequence Ontology term: antisense_lncRNA_gene
Transcripts: 66
Transcripts
Transcript ID | Location (hg38) | Length |
---|---|---|
lnc-IRX3-80:1 | chr16:54912772-54930942 | 8903 bp |
lnc-IRX3-80:10 | chr16:54918865-54929189 | 1144 bp |
lnc-IRX3-80:11 | chr16:54905876-54929172 | 18567 bp |
lnc-IRX3-80:12 | chr16:54913428-54929172 | 10739 bp |
lnc-IRX3-80:13 | chr16:54924859-54929172 | 758 bp |
lnc-IRX3-80:14 | chr16:54925153-54929172 | 464 bp |
lnc-IRX3-80:15 | chr16:54918866-54929167 | 1034 bp |
lnc-IRX3-80:16 | chr16:54919057-54929153 | 829 bp |
lnc-IRX3-80:17 | chr16:54918931-54929151 | 1092 bp |
lnc-IRX3-80:18 | chr16:54924859-54929149 | 735 bp |
lnc-IRX3-80:19 | chr16:54924937-54929133 | 641 bp |
lnc-IRX3-80:2 | chr16:54905876-54930578 | 19697 bp |
lnc-IRX3-80:20 | chr16:54919931-54929133 | 1023 bp |
lnc-IRX3-80:21 | chr16:54923281-54928886 | 600 bp |
lnc-IRX3-80:22 | chr16:54915380-54928886 | 13507 bp |
lnc-IRX3-80:23 | chr16:54916187-54928886 | 8332 bp |
lnc-IRX3-80:24 | chr16:54916187-54928886 | 6606 bp |
lnc-IRX3-80:25 | chr16:54918870-54928886 | 749 bp |
lnc-IRX3-80:26 | chr16:54919066-54928886 | 757 bp |
lnc-IRX3-80:27 | chr16:54919173-54928886 | 533 bp |
lnc-IRX3-80:28 | chr16:54923281-54928886 | 600 bp |
lnc-IRX3-80:29 | chr16:54912772-54928838 | 2705 bp |
lnc-IRX3-80:3 | chr16:54905876-54930578 | 18885 bp |
lnc-IRX3-80:30 | chr16:54892936-54928835 | 5766 bp |
lnc-IRX3-80:31 | chr16:54919173-54928812 | 459 bp |
lnc-IRX3-80:32 | chr16:54919260-54928809 | 4544 bp |
lnc-IRX3-80:33 | chr16:54918886-54928796 | 643 bp |
lnc-IRX3-80:34 | chr16:54918870-54928796 | 659 bp |
lnc-IRX3-80:35 | chr16:54918933-54928779 | 496 bp |
lnc-IRX3-80:36 | chr16:54918866-54928778 | 921 bp |
lnc-IRX3-80:37 | chr16:54918865-54928778 | 922 bp |
lnc-IRX3-80:38 | chr16:54918865-54928778 | 850 bp |
lnc-IRX3-80:39 | chr16:54919066-54928716 | 587 bp |
lnc-IRX3-80:4 | chr16:54905876-54930578 | 15622 bp |
lnc-IRX3-80:40 | chr16:54905876-54928564 | 17959 bp |
lnc-IRX3-80:41 | chr16:54918863-54928564 | 627 bp |
lnc-IRX3-80:42 | chr16:54918864-54928564 | 709 bp |
lnc-IRX3-80:43 | chr16:54912772-54928559 | 6796 bp |
lnc-IRX3-80:44 | chr16:54918932-54928551 | 628 bp |
lnc-IRX3-80:45 | chr16:54918886-54928551 | 591 bp |
lnc-IRX3-80:46 | chr16:54918863-54928551 | 614 bp |
lnc-IRX3-80:47 | chr16:54918864-54928551 | 696 bp |
lnc-IRX3-80:48 | chr16:54917939-54928500 | 1498 bp |
lnc-IRX3-80:49 | chr16:54912772-54928329 | 11296 bp |
lnc-IRX3-80:5 | chr16:54905876-54930578 | 18868 bp |
lnc-IRX3-80:50 | chr16:54851513-54928329 | 8721 bp |
lnc-IRX3-80:51 | chr16:54912772-54927660 | 8960 bp |
lnc-IRX3-80:52 | chr16:54919260-54925747 | 6488 bp |
lnc-IRX3-80:53 | chr16:54918960-54925199 | 415 bp |
lnc-IRX3-80:54 | chr16:54851640-54925144 | 2601 bp |
lnc-IRX3-80:55 | chr16:54851513-54924928 | 7213 bp |
lnc-IRX3-80:56 | chr16:54919054-54923779 | 464 bp |
lnc-IRX3-80:57 | chr16:54918870-54920616 | 659 bp |
lnc-IRX3-80:58 | chr16:54851513-54913442 | 2483 bp |
lnc-IRX3-80:59 | chr16:54889539-54893483 | 2340 bp |
lnc-IRX3-80:6 | chr16:54929419-54930578 | 1160 bp |
lnc-IRX3-80:60 | chr16:54847247-54874168 | 865 bp |
lnc-IRX3-80:61 | chr16:54851640-54852733 | 1094 bp |
lnc-IRX3-80:62 | chr16:54847203-54848488 | 719 bp |
lnc-IRX3-80:63 | chr16:54847033-54848297 | 363 bp |
lnc-IRX3-80:64 | chr16:54845189-54848278 | 546 bp |
lnc-IRX3-80:65 | chr16:54847247-54848233 | 420 bp |
lnc-IRX3-80:66 | chr16:54847249-54848233 | 418 bp |
lnc-IRX3-80:7 | chr16:54918932-54929641 | 1442 bp |
lnc-IRX3-80:8 | chr16:54925153-54929189 | 481 bp |
lnc-IRX3-80:9 | chr16:54918865-54929189 | 1057 bp |
Locus conservation
Available literature
- Xie (2016), Long non-coding RNAs in colorectal cancer., Oncotarget
- Cabanski (2015), Pan-cancer transcriptome analysis reveals long noncoding RNAs with conserved function., RNA Biol
- Chen (2015), Differential lncRNA expression profiles in recurrent gliomas compared with primary gliomas identified by microarray analysis., Int J Clin Exp Med
- Maguire (2015), SF3B1 mutations constitute a novel therapeutic target in breast cancer., J. Pathol.
- Pastori (2015), The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation., Proc. Natl. Acad. Sci. U.S.A.
- Ragusa (2015), Non-coding landscapes of colorectal cancer., World J. Gastroenterol.
- Szafron (2015), The Novel Gene CRNDE Encodes a Nuclear Peptide (CRNDEP) Which Is Overexpressed in Highly Proliferating Tissues., PLoS ONE
- Wang (2015), CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling., Cancer Lett.
- Zheng (2015), CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186., Oncotarget
- Barnhill (2014), High expression of CAI2, a 9p21-embedded long noncoding RNA, contributes to advanced-stage neuroblastoma., Cancer Res.
- Chi (2014), Role of BC040587 as a predictor of poor outcome in breast cancer., Cancer Cell Int.
- Guo (2014), BRAF-activated long non-coding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition., Oncol Lett
- Roberts (2014), The role of long non-coding RNAs in neurodevelopment, brain function and neurological disease., Philos. Trans. R. Soc. Lond., B, Biol. Sci.
- Furney (2013), SF3B1 mutations are associated with alternative splicing in uveal melanoma., Cancer Discov
- Graham (2011), Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas., Genes Cancer
- Lin (2011), RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders., PLoS ONE